ID   AOC3_HUMAN              Reviewed;         763 AA.
AC   Q16853; B2RCI5; K7ESB3; L0L8N9; Q45F94;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-JUN-2023, entry version 212.
DE   RecName: Full=Membrane primary amine oxidase;
DE            EC=1.4.3.21 {ECO:0000269|PubMed:19588076};
DE   AltName: Full=Copper amine oxidase;
DE   AltName: Full=HPAO;
DE   AltName: Full=Semicarbazide-sensitive amine oxidase;
DE            Short=SSAO;
DE   AltName: Full=Vascular adhesion protein 1;
DE            Short=VAP-1;
GN   Name=AOC3; Synonyms=VAP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=8972912; DOI=10.1016/s0378-1119(96)00387-3;
RA   Zhang X., McIntire W.S.;
RT   "Cloning and sequencing of a copper-containing, topaquinone-containing
RT   monoamine oxidase from human placenta.";
RL   Gene 179:279-286(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, FUNCTION,
RP   SELF-ASSOCIATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=9653080; DOI=10.1084/jem.188.1.17;
RA   Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S.;
RT   "Cloning of vascular adhesion protein 1 reveals a novel multifunctional
RT   adhesion molecule.";
RL   J. Exp. Med. 188:17-27(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14585497; DOI=10.1016/s0378-1119(03)00753-4;
RA   Zhang Q., Mashima Y., Noda S., Imamura Y., Kudoh J., Shimizu N.,
RA   Nishiyama T., Umeda S., Oguchi Y., Tanaka Y., Iwata T.;
RT   "Characterization of AOC2 gene encoding a copper-binding amine oxidase
RT   expressed specifically in retina.";
RL   Gene 318:45-53(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBUNIT, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=23349812; DOI=10.1371/journal.pone.0054151;
RA   Kaitaniemi S., Gron K., Elovaara H., Salmi M., Jalkanen S., Elima K.;
RT   "Functional modulation of vascular adhesion protein-1 by a novel splice
RT   variant.";
RL   PLoS ONE 8:E54151-E54151(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-5; TYR-167; THR-371;
RP   SER-408; HIS-426; TRP-441; THR-582; SER-700 AND VAL-749.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 79-90 AND 123-132.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/bj20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at the
RT   surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-592; ASN-618 AND ASN-666.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17400359; DOI=10.1016/j.biochi.2007.02.013;
RA   Bour S., Daviaud D., Gres S., Lefort C., Prevot D., Zorzano A.,
RA   Wabitsch M., Saulnier-Blache J.-S., Valet P., Carpene C.;
RT   "Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and
RT   monoamine oxidase in human adipocytes.";
RL   Biochimie 89:916-925(2007).
RN   [12]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, MUTAGENESIS OF MET-211;
RP   TYR-394 AND LEU-469, AND CATALYTIC ACTIVITY.
RX   PubMed=19588076; DOI=10.1007/s00018-009-0076-5;
RA   Kaitaniemi S., Elovaara H., Groen K., Kidron H., Liukkonen J., Salminen T.,
RA   Salmi M., Jalkanen S., Elima K.;
RT   "The unique substrate specificity of human AOC2, a semicarbazide-sensitive
RT   amine oxidase.";
RL   Cell. Mol. Life Sci. 66:2743-2757(2009).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-137; ASN-294; ASN-592; ASN-618
RP   AND ASN-666.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   GLYCOSYLATION AT ASN-592.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [15] {ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) IN COMPLEX WITH CALCIUM; COPPER AND
RP   SUBSTRATE, DISULFIDE BONDS, TOPAQUINONE AT TYR-471, AND GLYCOSYLATION AT
RP   ASN-137; THR-212; ASN-232; ASN-294; ASN-592; ASN-618 AND ASN-666.
RX   PubMed=16046623; DOI=10.1110/ps.051438105;
RA   Airenne T.T., Nymalm Y., Kidron H., Smith D.J., Pihlavisto M., Salmi M.,
RA   Jalkanen S., Johnson M.S., Salminen T.A.;
RT   "Crystal structure of the human vascular adhesion protein-1: unique
RT   structural features with functional implications.";
RL   Protein Sci. 14:1964-1974(2005).
CC   -!- FUNCTION: Cell adhesion protein that participates in lymphocyte
CC       extravasation and recirculation by mediating the binding of lymphocytes
CC       to peripheral lymph node vascular endothelial cells in an L-selectin-
CC       independent fashion. Has semicarbazide-sensitive (SSAO) monoamine
CC       oxidase activity. May play a role in adipogenesis.
CC       {ECO:0000269|PubMed:17400359, ECO:0000269|PubMed:19588076,
CC       ECO:0000269|PubMed:23349812, ECO:0000269|PubMed:9653080}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aliphatic amine + H2O + O2 = an aldehyde + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:16153, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17478, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58001; EC=1.4.3.21;
CC         Evidence={ECO:0000269|PubMed:19588076};
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC         Evidence={ECO:0000269|PubMed:16046623};
CC       Note=Binds 1 copper ion per subunit. {ECO:0000269|PubMed:16046623};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:16046623};
CC       Note=Binds 2 calcium ions per subunit. {ECO:0000269|PubMed:16046623};
CC   -!- COFACTOR:
CC       Name=L-topaquinone; Xref=ChEBI:CHEBI:79027;
CC         Evidence={ECO:0000269|PubMed:16046623};
CC       Note=Contains 1 topaquinone per subunit. {ECO:0000269|PubMed:16046623};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.94 mM for 2-phenylethylamine {ECO:0000269|PubMed:19588076};
CC         KM=0.67 mM for methylamine {ECO:0000269|PubMed:19588076};
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Can heterodimerize with isoform 2
CC       leading to reduced surface expression. Forms a heterodimer with AOC2.
CC       {ECO:0000269|PubMed:16046623, ECO:0000269|PubMed:19588076,
CC       ECO:0000269|PubMed:23349812}.
CC   -!- INTERACTION:
CC       Q16853; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-3921628, EBI-11343438;
CC       Q16853; O95484: CLDN9; NbExp=3; IntAct=EBI-3921628, EBI-18341636;
CC       Q16853; Q7Z7G2: CPLX4; NbExp=3; IntAct=EBI-3921628, EBI-18013275;
CC       Q16853; Q96BA8: CREB3L1; NbExp=3; IntAct=EBI-3921628, EBI-6942903;
CC       Q16853; Q6PI48: DARS2; NbExp=3; IntAct=EBI-3921628, EBI-3917045;
CC       Q16853; Q8TBE3: FNDC9; NbExp=3; IntAct=EBI-3921628, EBI-12142257;
CC       Q16853; Q7Z5P4: HSD17B13; NbExp=3; IntAct=EBI-3921628, EBI-18053395;
CC       Q16853; P42858: HTT; NbExp=3; IntAct=EBI-3921628, EBI-466029;
CC       Q16853; O43765: SGTA; NbExp=3; IntAct=EBI-3921628, EBI-347996;
CC       Q16853; Q16623: STX1A; NbExp=3; IntAct=EBI-3921628, EBI-712466;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9653080};
CC       Single-pass type II membrane protein {ECO:0000269|PubMed:9653080}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16853-1; Sequence=Displayed;
CC       Name=2; Synonyms=VAP-1Delta3;
CC         IsoId=Q16853-2; Sequence=VSP_053751, VSP_053752;
CC       Name=3;
CC         IsoId=Q16853-3; Sequence=VSP_055201;
CC   -!- TISSUE SPECIFICITY: Strongly expressed on the high endothelial venules
CC       of peripheral lymph nodes and on hepatic endothelia. Also highly
CC       expressed in appendix, lung and small intestine. Expressed also in
CC       adipose tissue, in bone marrow, colon, heart, kidney, ovary, pancreas,
CC       placenta, prostate, skeletal muscle, spleen and testis. Isoform 2 seems
CC       to be the predominant transcript in fetal kidneys, fetal cartilage and
CC       fetal tonsils. The highest relative expression of isoform 2 occurs in
CC       skeletal muscle, heart, pancreas, kidney, and lung.
CC       {ECO:0000269|PubMed:17400359, ECO:0000269|PubMed:23349812,
CC       ECO:0000269|PubMed:9653080}.
CC   -!- INDUCTION: Up-regulated during in vitro adipocyte differentiation.
CC       {ECO:0000269|PubMed:17400359}.
CC   -!- PTM: Topaquinone (TPQ) is generated by copper-dependent autoxidation of
CC       a specific tyrosyl residue. {ECO:0000269|PubMed:16046623}.
CC   -!- PTM: N- and O-glycosylated. {ECO:0000269|PubMed:16046623,
CC       ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19139490,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Devoid of the semicarbazide-sensitive amine
CC       oxidase (SSAO) activity. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the copper/topaquinone oxidase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/aoc3/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U39447; AAC50919.1; -; mRNA.
DR   EMBL; AF067406; AAC25170.1; -; mRNA.
DR   EMBL; AB050502; BAB18866.1; -; Genomic_DNA.
DR   EMBL; JX020506; AGB67480.1; -; mRNA.
DR   EMBL; AK025727; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK315129; BAG37582.1; -; mRNA.
DR   EMBL; DQ143944; AAZ38716.1; -; Genomic_DNA.
DR   EMBL; AC016889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050549; AAH50549.1; -; mRNA.
DR   CCDS; CCDS11444.1; -. [Q16853-1]
DR   CCDS; CCDS62198.1; -. [Q16853-3]
DR   CCDS; CCDS74071.1; -. [Q16853-2]
DR   PIR; JC5234; JC5234.
DR   RefSeq; NP_001264660.1; NM_001277731.1. [Q16853-2]
DR   RefSeq; NP_001264661.1; NM_001277732.1. [Q16853-3]
DR   RefSeq; NP_003725.1; NM_003734.3. [Q16853-1]
DR   PDB; 1PU4; X-ray; 3.20 A; A/B=1-763.
DR   PDB; 1US1; X-ray; 2.90 A; A/B=1-763.
DR   PDB; 2C10; X-ray; 2.50 A; A/B/C/D=29-763.
DR   PDB; 2C11; X-ray; 2.90 A; A/B/C/D=29-763.
DR   PDB; 2Y73; X-ray; 2.60 A; A/B=1-763.
DR   PDB; 2Y74; X-ray; 2.95 A; A/B=1-763.
DR   PDB; 3ALA; X-ray; 2.90 A; A/B/C/D/E/F/G=33-763.
DR   PDB; 4BTW; X-ray; 2.80 A; A/B=27-763.
DR   PDB; 4BTX; X-ray; 2.78 A; A/B=27-763.
DR   PDB; 4BTY; X-ray; 3.10 A; A/B=27-763.
DR   PDBsum; 1PU4; -.
DR   PDBsum; 1US1; -.
DR   PDBsum; 2C10; -.
DR   PDBsum; 2C11; -.
DR   PDBsum; 2Y73; -.
DR   PDBsum; 2Y74; -.
DR   PDBsum; 3ALA; -.
DR   PDBsum; 4BTW; -.
DR   PDBsum; 4BTX; -.
DR   PDBsum; 4BTY; -.
DR   AlphaFoldDB; Q16853; -.
DR   SMR; Q16853; -.
DR   BioGRID; 114192; 58.
DR   IntAct; Q16853; 19.
DR   STRING; 9606.ENSP00000312326; -.
DR   BindingDB; Q16853; -.
DR   ChEMBL; CHEMBL3437; -.
DR   DrugBank; DB04334; 6-hydroxydopa quinone.
DR   DrugBank; DB01275; Hydralazine.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugCentral; Q16853; -.
DR   GuidetoPHARMACOLOGY; 2767; -.
DR   GlyConnect; 1502; 9 N-Linked glycans (4 sites).
DR   GlyCosmos; Q16853; 8 sites, 9 glycans.
DR   GlyGen; Q16853; 8 sites, 8 N-linked glycans (3 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q16853; -.
DR   PhosphoSitePlus; Q16853; -.
DR   BioMuta; AOC3; -.
DR   DMDM; 2501336; -.
DR   jPOST; Q16853; -.
DR   MassIVE; Q16853; -.
DR   PaxDb; Q16853; -.
DR   PeptideAtlas; Q16853; -.
DR   ProteomicsDB; 61105; -. [Q16853-1]
DR   ABCD; Q16853; 8 sequenced antibodies.
DR   Antibodypedia; 611; 490 antibodies from 39 providers.
DR   DNASU; 8639; -.
DR   Ensembl; ENST00000308423.7; ENSP00000312326.1; ENSG00000131471.7. [Q16853-1]
DR   Ensembl; ENST00000591562.1; ENSP00000468632.1; ENSG00000131471.7. [Q16853-3]
DR   Ensembl; ENST00000613571.1; ENSP00000484312.1; ENSG00000131471.7. [Q16853-2]
DR   Ensembl; ENST00000617500.4; ENSP00000477686.1; ENSG00000131471.7. [Q16853-3]
DR   GeneID; 8639; -.
DR   KEGG; hsa:8639; -.
DR   MANE-Select; ENST00000308423.7; ENSP00000312326.1; NM_003734.4; NP_003725.1.
DR   UCSC; uc002ibv.6; human. [Q16853-1]
DR   AGR; HGNC:550; -.
DR   CTD; 8639; -.
DR   DisGeNET; 8639; -.
DR   GeneCards; AOC3; -.
DR   HGNC; HGNC:550; AOC3.
DR   HPA; ENSG00000131471; Tissue enhanced (adipose).
DR   MIM; 603735; gene.
DR   neXtProt; NX_Q16853; -.
DR   OpenTargets; ENSG00000131471; -.
DR   PharmGKB; PA24840; -.
DR   VEuPathDB; HostDB:ENSG00000131471; -.
DR   eggNOG; KOG1186; Eukaryota.
DR   GeneTree; ENSGT00950000183207; -.
DR   HOGENOM; CLU_015739_1_0_1; -.
DR   InParanoid; Q16853; -.
DR   OMA; CMFEIDK; -.
DR   OrthoDB; 5490352at2759; -.
DR   PhylomeDB; Q16853; -.
DR   TreeFam; TF314750; -.
DR   BRENDA; 1.4.3.21; 2681.
DR   PathwayCommons; Q16853; -.
DR   Reactome; R-HSA-211945; Phase I - Functionalization of compounds.
DR   SABIO-RK; Q16853; -.
DR   SignaLink; Q16853; -.
DR   BioGRID-ORCS; 8639; 11 hits in 1147 CRISPR screens.
DR   ChiTaRS; AOC3; human.
DR   EvolutionaryTrace; Q16853; -.
DR   GeneWiki; AOC3; -.
DR   GenomeRNAi; 8639; -.
DR   Pharos; Q16853; Tchem.
DR   PRO; PR:Q16853; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q16853; protein.
DR   Bgee; ENSG00000131471; Expressed in blood vessel layer and 176 other tissues.
DR   ExpressionAtlas; Q16853; baseline and differential.
DR   Genevisible; Q16853; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IDA:CACAO.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:CACAO.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:CACAO.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005507; F:copper ion binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IDA:UniProtKB.
DR   GO; GO:0052593; F:tryptamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0009308; P:amine metabolic process; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:1902283; P:negative regulation of primary amine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0046677; P:response to antibiotic; IDA:UniProtKB.
DR   Gene3D; 3.10.450.40; -; 2.
DR   Gene3D; 2.70.98.20; Copper amine oxidase, catalytic domain; 1.
DR   InterPro; IPR000269; Cu_amine_oxidase.
DR   InterPro; IPR015798; Cu_amine_oxidase_C.
DR   InterPro; IPR036460; Cu_amine_oxidase_C_sf.
DR   InterPro; IPR016182; Cu_amine_oxidase_N-reg.
DR   InterPro; IPR015800; Cu_amine_oxidase_N2.
DR   InterPro; IPR015802; Cu_amine_oxidase_N3.
DR   PANTHER; PTHR10638; COPPER AMINE OXIDASE; 1.
DR   PANTHER; PTHR10638:SF85; MEMBRANE PRIMARY AMINE OXIDASE; 1.
DR   Pfam; PF01179; Cu_amine_oxid; 1.
DR   Pfam; PF02727; Cu_amine_oxidN2; 1.
DR   Pfam; PF02728; Cu_amine_oxidN3; 1.
DR   PRINTS; PR00766; CUDAOXIDASE.
DR   SUPFAM; SSF49998; Amine oxidase catalytic domain; 1.
DR   SUPFAM; SSF54416; Amine oxidase N-terminal region; 2.
DR   PROSITE; PS01164; COPPER_AMINE_OXID_1; 1.
DR   PROSITE; PS01165; COPPER_AMINE_OXID_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Copper; Direct protein sequencing; Disulfide bond; Glycoprotein; Membrane;
KW   Metal-binding; Oxidoreductase; Reference proteome; Signal-anchor; TPQ;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..763
FT                   /note="Membrane primary amine oxidase"
FT                   /id="PRO_0000064102"
FT   TOPO_DOM        1..5
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        6..26
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        27..763
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        386
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   ACT_SITE        471
FT                   /note="Schiff-base intermediate with substrate; via
FT                   topaquinone"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2Y73"
FT   BINDING         384..394
FT                   /ligand="substrate"
FT                   /evidence="ECO:0007744|PDB:4BTY"
FT   BINDING         468..473
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   BINDING         520
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         522
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         529
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         530
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         531
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         572
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         638
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C11"
FT   BINDING         641
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007744|PDB:4BTW"
FT   BINDING         663
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         665
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         667
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         673
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         674
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   BINDING         684
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   MOD_RES         471
FT                   /note="2',4',5'-topaquinone"
FT                   /evidence="ECO:0007744|PDB:1PU4"
FT   CARBOHYD        137
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0000269|PubMed:19159218, ECO:0007744|PDB:1PU4,
FT                   ECO:0007744|PDB:1US1, ECO:0007744|PDB:2C10,
FT                   ECO:0007744|PDB:2C11, ECO:0007744|PDB:2Y73,
FT                   ECO:0007744|PDB:2Y74, ECO:0007744|PDB:3ALA,
FT                   ECO:0007744|PDB:4BTW, ECO:0007744|PDB:4BTX,
FT                   ECO:0007744|PDB:4BTY"
FT   CARBOHYD        212
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:16046623"
FT   CARBOHYD        232
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0007744|PDB:1PU4, ECO:0007744|PDB:1US1,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:3ALA, ECO:0007744|PDB:4BTW,
FT                   ECO:0007744|PDB:4BTX, ECO:0007744|PDB:4BTY"
FT   CARBOHYD        294
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0000269|PubMed:19159218, ECO:0007744|PDB:2C10,
FT                   ECO:0007744|PDB:2C11, ECO:0007744|PDB:4BTY"
FT   CARBOHYD        592
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19139490,
FT                   ECO:0000269|PubMed:19159218, ECO:0007744|PDB:2C10,
FT                   ECO:0007744|PDB:2C11, ECO:0007744|PDB:2Y73,
FT                   ECO:0007744|PDB:2Y74, ECO:0007744|PDB:3ALA,
FT                   ECO:0007744|PDB:4BTW, ECO:0007744|PDB:4BTX,
FT                   ECO:0007744|PDB:4BTY"
FT   CARBOHYD        618
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218,
FT                   ECO:0007744|PDB:4BTW, ECO:0007744|PDB:4BTX"
FT   CARBOHYD        666
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16046623,
FT                   ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218,
FT                   ECO:0007744|PDB:2C10, ECO:0007744|PDB:2C11,
FT                   ECO:0007744|PDB:2Y73, ECO:0007744|PDB:2Y74,
FT                   ECO:0007744|PDB:4BTW, ECO:0007744|PDB:4BTX,
FT                   ECO:0007744|PDB:4BTY"
FT   DISULFID        198..199
FT                   /evidence="ECO:0000269|PubMed:16046623"
FT   DISULFID        404..430
FT                   /evidence="ECO:0000250|UniProtKB:P19801"
FT   DISULFID        734..741
FT                   /evidence="ECO:0000269|PubMed:16046623"
FT   DISULFID        748
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:16046623"
FT   VAR_SEQ         1..543
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055201"
FT   VAR_SEQ         630..634
FT                   /note="YQLAV -> IWWPG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:23349812"
FT                   /id="VSP_053751"
FT   VAR_SEQ         635..763
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:23349812"
FT                   /id="VSP_053752"
FT   VARIANT         5
FT                   /note="T -> R (in dbSNP:rs33954211)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025035"
FT   VARIANT         78
FT                   /note="R -> Q (in dbSNP:rs402680)"
FT                   /id="VAR_052603"
FT   VARIANT         167
FT                   /note="H -> Y (in dbSNP:rs2228470)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025027"
FT   VARIANT         171
FT                   /note="V -> M (in dbSNP:rs408038)"
FT                   /id="VAR_052604"
FT   VARIANT         203
FT                   /note="H -> R (in dbSNP:rs630079)"
FT                   /id="VAR_052605"
FT   VARIANT         317
FT                   /note="Y -> H (in dbSNP:rs438287)"
FT                   /id="VAR_012064"
FT   VARIANT         329
FT                   /note="R -> Q (in dbSNP:rs2229595)"
FT                   /id="VAR_024343"
FT   VARIANT         371
FT                   /note="I -> T (in dbSNP:rs35097308)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025028"
FT   VARIANT         408
FT                   /note="A -> S (in dbSNP:rs35643019)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025029"
FT   VARIANT         426
FT                   /note="R -> H (in dbSNP:rs33986943)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025030"
FT   VARIANT         441
FT                   /note="R -> W (in dbSNP:rs2229596)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025031"
FT   VARIANT         582
FT                   /note="A -> T (in dbSNP:rs34987927)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025032"
FT   VARIANT         700
FT                   /note="G -> S (in dbSNP:rs477207)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025033"
FT   VARIANT         749
FT                   /note="A -> V (in dbSNP:rs34012919)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_025034"
FT   MUTAGEN         211
FT                   /note="M->V: Increased activity towards 2-phenylethylamine,
FT                   and decreased activity towards methylamine; when associated
FT                   with N-394 and G-469."
FT                   /evidence="ECO:0000269|PubMed:19588076"
FT   MUTAGEN         394
FT                   /note="Y->N: Increased activity towards 2-phenylethylamine,
FT                   and decreased activity towards methylamine; when associated
FT                   with V-211 and G-469."
FT                   /evidence="ECO:0000269|PubMed:19588076"
FT   MUTAGEN         469
FT                   /note="L->G: Increased activity towards 2-phenylethylamine,
FT                   and decreased activity towards methylamine; when associated
FT                   with V-211 and N-394."
FT                   /evidence="ECO:0000269|PubMed:19588076"
FT   HELIX           65..78
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:3ALA"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          93..102
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           106..115
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          123..130
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          137..144
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          151..154
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           156..160
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           166..168
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           173..185
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           188..191
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           192..199
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            203..206
FT                   /evidence="ECO:0007829|PDB:2C11"
FT   STRAND          208..211
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          217..219
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          224..231
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          234..236
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           238..240
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          242..250
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          260..266
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          269..272
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           274..282
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            283..285
FT                   /evidence="ECO:0007829|PDB:4BTW"
FT   TURN            298..300
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          318..320
FT                   /evidence="ECO:0007829|PDB:4BTW"
FT   STRAND          322..326
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          329..342
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            343..345
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          346..354
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          357..372
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           377..380
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          383..385
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           386..388
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            391..394
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            400..402
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          408..421
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          423..445
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          447..449
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          451..468
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          471..479
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            481..483
FT                   /evidence="ECO:0007829|PDB:4BTY"
FT   STRAND          485..493
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          497..499
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          506..512
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          515..518
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          520..530
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          534..551
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          554..569
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           572..575
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          577..581
FT                   /evidence="ECO:0007829|PDB:4BTW"
FT   STRAND          585..594
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          600..608
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          617..619
FT                   /evidence="ECO:0007829|PDB:2C11"
FT   HELIX           622..629
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          630..636
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            647..651
FT                   /evidence="ECO:0007829|PDB:2Y73"
FT   STRAND          653..655
FT                   /evidence="ECO:0007829|PDB:1US1"
FT   HELIX           660..663
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          670..684
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           688..690
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          700..713
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           715..718
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   STRAND          723..729
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   TURN            734..736
FT                   /evidence="ECO:0007829|PDB:2C10"
FT   HELIX           738..741
FT                   /evidence="ECO:0007829|PDB:2Y73"
FT   HELIX           742..745
FT                   /evidence="ECO:0007829|PDB:2C10"
SQ   SEQUENCE   763 AA;  84622 MW;  58AD55605EC9D228 CRC64;
     MNQKTILVLL ILAVITIFAL VCVLLVGRGG DGGEPSQLPH CPSVSPSAQP WTHPGQSQLF
     ADLSREELTA VMRFLTQRLG PGLVDAAQAR PSDNCVFSVE LQLPPKAAAL AHLDRGSPPP
     AREALAIVFF GRQPQPNVSE LVVGPLPHPS YMRDVTVERH GGPLPYHRRP VLFQEYLDID
     QMIFNRELPQ ASGLLHHCCF YKHRGRNLVT MTTAPRGLQS GDRATWFGLY YNISGAGFFL
     HHVGLELLVN HKALDPARWT IQKVFYQGRY YDSLAQLEAQ FEAGLVNVVL IPDNGTGGSW
     SLKSPVPPGP APPLQFYPQG PRFSVQGSRV ASSLWTFSFG LGAFSGPRIF DVRFQGERLV
     YEISLQEALA IYGGNSPAAM TTRYVDGGFG MGKYTTPLTR GVDCPYLATY VDWHFLLESQ
     APKTIRDAFC VFEQNQGLPL RRHHSDLYSH YFGGLAETVL VVRSMSTLLN YDYVWDTVFH
     PSGAIEIRFY ATGYISSAFL FGATGKYGNQ VSEHTLGTVH THSAHFKVDL DVAGLENWVW
     AEDMVFVPMA VPWSPEHQLQ RLQVTRKLLE MEEQAAFLVG SATPRYLYLA SNHSNKWGHP
     RGYRIQMLSF AGEPLPQNSS MARGFSWERY QLAVTQRKEE EPSSSSVFNQ NDPWAPTVDF
     SDFINNETIA GKDLVAWVTA GFLHIPHAED IPNTVTVGNG VGFFLRPYNF FDEDPSFYSA
     DSIYFRGDQD AGACEVNPLA CLPQAAACAP DLPAFSHGGF SHN
//
